High-dose reirradiation with intensity-modulated radiotherapy for recurrent head-and-neck cancer: Disease control, survival and toxicity.
- Author
- Fréderic Duprez (UGent) , Dieter Berwouts, Indira Madani (UGent) , Katrien Bonte, Tom Boterberg (UGent) , Werner De Gersem (UGent) , Philippe Deron (UGent) , Wouter Huvenne (UGent) and Wilfried De Neve (UGent)
- Organization
- Keywords
- Toxicity, SQUAMOUS-CELL CARCINOMA, Reirradiation, IMRT, Head-and-neck cancer, Radiotherapy, OUTCOMES, FEASIBILITY, TRIAL, SALVAGE SURGERY, RADIATION-THERAPY, LOCALLY-RECURRENT, CAROTID BLOWOUT, CHEMOTHERAPY, CETUXIMAB
Downloads
-
(...).pdf
- full text
- |
- UGent only
- |
- |
- 717.09 KB
Citation
Please use this url to cite or link to this publication: http://hdl.handle.net/1854/LU-5663595
- MLA
- Duprez, Fréderic, et al. “High-Dose Reirradiation with Intensity-Modulated Radiotherapy for Recurrent Head-and-Neck Cancer: Disease Control, Survival and Toxicity.” RADIOTHERAPY AND ONCOLOGY, vol. 111, no. 3, 2014, pp. 388–92, doi:10.1016/j.radonc.2014.04.018.
- APA
- Duprez, F., Berwouts, D., Madani, I., Bonte, K., Boterberg, T., De Gersem, W., … De Neve, W. (2014). High-dose reirradiation with intensity-modulated radiotherapy for recurrent head-and-neck cancer: Disease control, survival and toxicity. RADIOTHERAPY AND ONCOLOGY, 111(3), 388–392. https://doi.org/10.1016/j.radonc.2014.04.018
- Chicago author-date
- Duprez, Fréderic, Dieter Berwouts, Indira Madani, Katrien Bonte, Tom Boterberg, Werner De Gersem, Philippe Deron, Wouter Huvenne, and Wilfried De Neve. 2014. “High-Dose Reirradiation with Intensity-Modulated Radiotherapy for Recurrent Head-and-Neck Cancer: Disease Control, Survival and Toxicity.” RADIOTHERAPY AND ONCOLOGY 111 (3): 388–92. https://doi.org/10.1016/j.radonc.2014.04.018.
- Chicago author-date (all authors)
- Duprez, Fréderic, Dieter Berwouts, Indira Madani, Katrien Bonte, Tom Boterberg, Werner De Gersem, Philippe Deron, Wouter Huvenne, and Wilfried De Neve. 2014. “High-Dose Reirradiation with Intensity-Modulated Radiotherapy for Recurrent Head-and-Neck Cancer: Disease Control, Survival and Toxicity.” RADIOTHERAPY AND ONCOLOGY 111 (3): 388–392. doi:10.1016/j.radonc.2014.04.018.
- Vancouver
- 1.Duprez F, Berwouts D, Madani I, Bonte K, Boterberg T, De Gersem W, et al. High-dose reirradiation with intensity-modulated radiotherapy for recurrent head-and-neck cancer: Disease control, survival and toxicity. RADIOTHERAPY AND ONCOLOGY. 2014;111(3):388–92.
- IEEE
- [1]F. Duprez et al., “High-dose reirradiation with intensity-modulated radiotherapy for recurrent head-and-neck cancer: Disease control, survival and toxicity.,” RADIOTHERAPY AND ONCOLOGY, vol. 111, no. 3, pp. 388–392, 2014.
@article{5663595, author = {{Duprez, Fréderic and Berwouts, Dieter and Madani, Indira and Bonte, Katrien and Boterberg, Tom and De Gersem, Werner and Deron, Philippe and Huvenne, Wouter and De Neve, Wilfried}}, issn = {{0167-8140}}, journal = {{RADIOTHERAPY AND ONCOLOGY}}, keywords = {{Toxicity,SQUAMOUS-CELL CARCINOMA,Reirradiation,IMRT,Head-and-neck cancer,Radiotherapy,OUTCOMES,FEASIBILITY,TRIAL,SALVAGE SURGERY,RADIATION-THERAPY,LOCALLY-RECURRENT,CAROTID BLOWOUT,CHEMOTHERAPY,CETUXIMAB}}, language = {{eng}}, number = {{3}}, pages = {{388--392}}, title = {{High-dose reirradiation with intensity-modulated radiotherapy for recurrent head-and-neck cancer: Disease control, survival and toxicity.}}, url = {{http://doi.org/10.1016/j.radonc.2014.04.018}}, volume = {{111}}, year = {{2014}}, }
- Altmetric
- View in Altmetric
- Web of Science
- Times cited: